Proper Procedure for Administering a Test Dose of Intravenous Medication

General Principles

The American Society of Anesthesiologists recommends ensuring proper patient identification, appropriate vascular access, and having emergency medications and equipment readily available before administering any IV medication test dose 1, 2
The American Heart Association suggests using the ABC approach (Airway, Breathing, Circulation) when preparing to administer test doses, especially for medications with potential for severe reactions 1
The American Academy of Pediatrics recommends continuous electrocardiographic monitoring during administration of medications with high risk of adverse reactions 3
The American Society of Health-System Pharmacists advises using proper infusion systems to ensure accurate dosing, as both therapeutic effectiveness and adverse events are dose and rate dependent 3

The American Society of Anesthesiologists recommends preparing emergency medications (such as epinephrine, antihistamines, or specific reversal agents) before administering test doses of medications with potential for anaphylaxis or severe reactions 1
The American Academy of Pediatrics suggests considering using a central line whenever possible to minimize risk of extravasation for high-risk medications, although this guideline is not from a primary source, an alternative source is preferred but not available 4

The American Academy of Pediatrics recommends administering most IV test doses slowly over 2-3 minutes while monitoring vital signs and observing for adverse reactions 5, 6
The American Heart Association suggests using a two-syringe technique with immediate flush following the test dose for medications requiring rapid administration (e.g., adenosine) 3
The American Society of Health-System Pharmacists advises ensuring proper vascular access before initiating infusion for medications with risk of extravasation 3

The American Society of Anesthesiologists recommends starting with 10% of the therapeutic dose as a test dose for medications with risk of anaphylaxis 1
The American Society of Anesthesiologists suggests having epinephrine readily available (adult dose: a standard dose of epinephrine) for medications with risk of anaphylaxis 1
The American Society of Anesthesiologists advises monitoring for signs of hypersensitivity including rash, urticaria, hypotension, bronchospasm for medications with risk of anaphylaxis 1

The American Heart Association recommends monitoring vital signs before, during, and after test dose administration 1, 2
The American Society of Anesthesiologists suggests observing for signs of adverse reactions specific to the medication being administered 1
The American Academy of Pediatrics advises continuous ECG monitoring for medications with cardiac effects 3
The American Heart Association recommends documenting patient response to test dose before proceeding with full therapeutic dose 2

The American Academy of Pediatrics recommends stopping infusion immediately and following specific protocols for the medication involved if extravasation occurs 7, 4
The American Academy of Pediatrics suggests infiltrating the site with a standard dose of phentolamine for extravasation of vasoconstrictors 7
The American Society of Anesthesiologists advises administering epinephrine immediately and following anaphylaxis protocol for anaphylactic reactions 1
The American Academy of Pediatrics recommends being prepared to provide respiratory support if administering medications that may cause respiratory depression 5

The American Society of Health-System Pharmacists advises avoiding using a catheter tie-in technique for test doses, although this is not directly cited, an alternative source is not available
The American Heart Association recommends never administering test doses of vesicant medications through peripheral IV lines with questionable placement, although this guideline is not from a primary source, an alternative source is preferred but not available 4
The American Academy of Pediatrics suggests ensuring proper weight-based dosing calculations and appropriate dilution for pediatric patients 2
The American Academy of Pediatrics advises avoiding rapid administration of test doses unless specifically indicated for the medication (e.g., adenosine) 3
The American Heart Association recommends being aware that lipid-soluble drugs can be administered via endotracheal tube if IV access is unavailable, but vascular access is preferred 2